SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001679082-19-000027
Filing Date
2019-08-06
Accepted
2019-08-06 16:13:37
Documents
16
Period of Report
2019-08-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8-kq1june302019myovant.htm   iXBRL 8-K 54438
2 EXHIBIT 99.1 a6302019myovantex991.htm EX-99.1 102041
8 myovant14.jpg GRAPHIC 14626
  Complete submission text file 0001679082-19-000027.txt   338118

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT myov-20190805.xsd EX-101.SCH 4567
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT myov-20190805_cal.xml EX-101.CAL 610
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT myov-20190805_def.xml EX-101.DEF 1460
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT myov-20190805_lab.xml EX-101.LAB 28168
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT myov-20190805_pre.xml EX-101.PRE 14574
9 EXTRACTED XBRL INSTANCE DOCUMENT a8-kq1june302019myovant_htm.xml XML 4656
Mailing Address SUITE 1, 3RD FLOOR 11-12 ST. JAMES SQUARE LONDON X0 SW1Y 4LB
Business Address SUITE 1, 3RD FLOOR 11-12 ST. JAMES SQUARE LONDON X0 SW1Y 4LB 44(0)207 400 3347
Myovant Sciences Ltd. (Filer) CIK: 0001679082 (see all company filings)

IRS No.: 000000000 | State of Incorp.: CA | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-37929 | Film No.: 191002210
SIC: 2834 Pharmaceutical Preparations